The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk ...

MS patients show large differences between vascular age and chronological age, even if they don't have cardiovascular disease ...

Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.

Immutep said IMP761 was found safe in initial data from a Phase 1 trial, with no treatment-related adverse events reported.

A rising incidence of MS diagnosed among older adults in a Sicilian province has been evident since 2005, particularly for ...

Columnist Desiree Lama, a lifelong Texan, struggles with the region's extreme heat, which can cause her MS symptoms to flare ...

Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, ...

Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough ...

Columnist Desiree Lama has been living with MS for several years, yet she still appreciatea the advice and advocacy of her ...

About four in five adults with long-term stable MS who stopped first-line treatment with a DMT showed signs of disease ...

Columnist Ahna Crum knows what MS has taken from her, but she also recognizes the significant gifts it's granted over the ...

A high genetic risk for MS, along with exposure to tobacco or other environmental factors, can affect early brain development ...